To Bleed or Not to Bleed: Dual versus Triple Therapy in Patients with Acute Coronary Syndrome Atrial Fibrillation

April 29, 2021

The presentation will focus on evidence-based information regarding antithrombotic therapy in patients with acute coronary syndrome (ACS) and atrial fibrillation (AF). The presentation will also highlight current literature related to dual versus triple therapy. Exposure to patients receiving these therapies may differ between pharmacists, but it is imperative that all clinicians understand how to appropriately manage said patients. Consequently, the presentation will provide case-based application questions. As such, pharmacists who are familiar with this patient population and those who are not will gain knowledge that will enable them to provide safe and effective care. This presentation is a great importance to Slidell Memorial Hospital’s patients due to the majority of them being cardiac patients.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Describe the pathophysiology of AF and ACS.
  2. Differentiate the associated mechanism of action, warnings, adverse effects, and dose adjustments of antithrombotic agents.
  3. Distinguish appropriate therapy (dual vs. triple) for patients post-ACS with concomitant AF based on current evidence.

Pharmacy technician learning objectives

  1. Identify brand/generic name of the antithrombotic agents used in post-acute coronary syndrome (ACS) and atrial fibrillation.
  2. Recognize different dosage strengths of antithrombotic agents.

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Course opens: 
04/29/2021
Course expires: 
06/13/2021
Event starts: 
04/29/2021 - 3:00pm CDT
Event ends: 
04/29/2021 - 4:00pm CDT
Slidell Memorial Hospital
Slidell, LA
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose.
 
Planning committee members
 
Uyen Vu, PharmD
PGY-1 Pharmacy Resident
Slidell Memorial Hospital
 
India Scales, PharmD
Clinical Pharmacist/PGY-1 Preceptor
Slidell Memorial Hospital
 
Elina Delgado, PharmD, BCPS
Clinical Pharmacist/PGY-1 Preceptor
Slidell Memorial Hospital
 
Course reviewer
 
Gretchen Brummel, PharmD, BCPS
Consulting Director, Pharmacy
Vizient, Inc.
 
Presenter
 
Uyen Vu, PharmD
PGY-1 Pharmacy Resident
Slidell Memorial Hospital
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Slidell Memorial Hospital.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-21-127-L01-P
Universal Activity Number: JA0006103-9999-21-127-L01-T

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Please login or register to take this course.